4.5 Article

Crosstalk between stem cell and cell cycle machineries

Journal

CURRENT OPINION IN CELL BIOLOGY
Volume 37, Issue -, Pages 68-74

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2015.10.001

Keywords

-

Categories

Funding

  1. Lucile Packard Foundation
  2. NIH [CA114102]
  3. New York Stem Cell Foundation-Robertson Investigator
  4. Tashia and John Morgridge Faculty Scholar
  5. Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases

Ask authors/readers for more resources

Pluripotent stem cells, defined by an unlimited self-renewal capacity and an undifferentiated state, are best typified by embryonic stem cells. These cells have a unique cell cycle compared to somatic cells as defined by a rapid progression through the cell cycle and a minimal time spent in G1. Recent reports indicate that pluripotency and cell cycle regulation are mechanistically linked. In this review, we discuss the reciprocal co-regulation of these processes, how this co-regulation may prevent differentiation, and how cellular reprogramming can re-establish the unique cell cycle regulation in induced pluripotent stem cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell & Tissue Engineering

Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and Tumorigenesis

Michael S. Kareta, Laura L. Gorges, Sana Hafeez, Berenice A. Benayoun, Samuele Marro, Anne-Flore Zmoos, Matthew J. Cecchini, Damek Spacek, Luis F. Z. Batista, Megan O'Brien, Yi-Han Ng, Cheen Euong Ang, Dedeepya Vaka, Steven E. Artandi, Frederick A. Dick, Anne Brunet, Julien Sage, Marius Wernig

CELL STEM CELL (2015)

Meeting Abstract Oncology

Sox2 functions as a critical oncogene in Rb loss initiated tumors

Michael S. Kareta, Megan O'Brien, Marius Wernig, Julien Sage

MOLECULAR CANCER RESEARCH (2016)

Article Cell Biology

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

Nadine S. Jahchan, Jing Shan Lim, Becky Bola, Karen Morris, Garrett Seitz, Kim Q. Tran, Lei Xu, Francesca Trapani, Christopher J. Morrow, Sandra Cristea, Garry L. Coles, Dian Yang, Dedeepya Vaka, Michael S. Kareta, Julie George, Pawel K. Mazur, Thuyen Nguyen, Wade C. Anderson, Scott J. Dylla, Fiona Blackhall, Martin Peifer, Caroline Dive, Julien Sage

CELL REPORTS (2016)

Article Multidisciplinary Sciences

Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates

Moritz Mall, Michael S. Kareta, Soham Chanda, Henrik Ahlenius, Nicholas Perotti, Bo Zhou, Sarah D. Grieder, Xuecai Ge, Sienna Drake, Cheen Euong Ang, Brandon M. Walker, Thomas Vierbuchen, Daniel R. Fuentes, Philip Brennecke, Kazuhiro R. Nitta, Arttu Jolma, Lars M. Steinmetz, Jussi Taipale, Thomas C. Sudhof, Marius Wernig

NATURE (2017)

Article Biochemistry & Molecular Biology

Recognition of Multivalent Histone States Associated with Heterochromatin by UHRF1 Protein

Nataliya Nady, Alexander Lemak, John R. Walker, George V. Avvakumov, Michael S. Kareta, Mayada Achour, Sheng Xue, Shili Duan, Abdellah Allali-Hassani, Xiaobing Zuo, Yun-Xing Wang, Christian Bronner, Frederic Chedin, Cheryl H. Arrowsmith, Sirano Dhe-Paganon

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Genetics & Heredity

Tandem E2F Binding Sites in the Promoter of the p107 Cell Cycle Regulator Control p107 Expression and Its Cellular Functions

Deborah L. Burkhart, Stacey E. Wirt, Anne-Flore Zmoos, Michael S. Kareta, Julien Sage

PLOS GENETICS (2010)

Editorial Material Multidisciplinary Sciences

Cancer origins-genetics rules the day

Michael S. Kareta, Julien Sage

SCIENCE (2018)

Article Biology

Global DNA methylation remodeling during direct reprogramming of fibroblasts to neurons

Chongyuan Luo, Qian Yi Lee, Orly Wapinski, Rosa Castanon, Joseph R. Nery, Moritz Malin, Michael S. Kareta, Sean M. Cullen, Margaret A. Goodell, Howard Y. Chang, Marius Wernig, Joseph R. Ecker

ELIFE (2019)

Article Oncology

YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators

Sany Hoxha, Alyssa Shepard, Scott Troutman, Huitian Diao, Joanne R. Doherty, Michalina Janiszewska, Robert M. Witwicki, Matthew E. Pipkin, William W. Ja, Michael S. Kareta, Joseph L. Kissil

CANCER RESEARCH (2020)

Article Cell Biology

Pro-neuronal activity of Myod1 due to promiscuous binding to neuronal genes

Qian Yi Lee, Moritz Mall, Soham Chanda, Bo Zhou, Kylesh S. Sharma, Katie Schaukowitch, Juan M. Adrian-Segarra, Sarah D. Grieder, Michael S. Kareta, Orly L. Wapinski, Cheen Euong Ang, Rui Li, Thomas C. Sudhof, Howard Y. Chang, Marius Wernig

NATURE CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Transcriptional regulation of miR-30a by YAP impacts PTPN13 and KLF9 levels and Schwann cell proliferation

Alyssa Shepard, Sany Hoxha, Scott Troutman, David Harbaugh, Michael S. Kareta, Joseph L. Kissil

Summary: The Hippo pathway is tightly regulated by mechanical cues and YAP acts as a key transcriptional regulator. Through regulating miR-30a expression in Schwann cells, YAP influences cell proliferation and death decisions.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Oncology

Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype

Ellen Voigt, Madeline Wallenburg, Hannah Wollenzien, Ethan Thompson, Kirtana Kumar, Joshua Feiner, Moira McNally, Hunter Friesen, Malini Mukherjee, Yohannes Afeworki, Michael S. Kareta

MOLECULAR CANCER RESEARCH (2021)

Article Oncology

Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer

Hannah Wollenzien, Yohannes Afeworki Tecleab, Robert Szczepaniak-Sloane, Anthony Restaino, Michael S. Kareta

Summary: Small cell lung cancer (SCLC) is a heterogeneous tumor with multiple populations of phenotypically different cells that contribute differently to tumor dynamics. Understanding the evolutionary dynamics of SCLC can shed light on key mechanisms such as cellular plasticity, heterogeneity, and chemoresistance. Cancer testis antigens (CTA) PAGE5 and GAGE2A have been identified as mediators of chemoresistance in human SCLC, and may be a promising avenue for targeted therapy.

MOLECULAR CANCER RESEARCH (2023)

Article Oncology

Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2

Joanne Doherty, Vinay Mandati, Maria A. Gonzalez Rodriguez, Scott Troutman, Alyssa Shepard, David Harbaugh, Rachel Brody, Douglas C. Miller, Michael S. Kareta, Joseph L. Kissil

Summary: Research found that NF2-deficient Schwann and schwannoma cells are sensitive to BET inhibition, primarily mediated by BRD4, which is overexpressed in human vestibular schwannomas. These results suggest that BRD4 regulates PI3K signaling and likely impedes NF2 schwannoma growth via this inhibition, implicating BET inhibition as a therapeutic option for NF2-deficient schwannomas.

NEURO-ONCOLOGY ADVANCES (2022)

No Data Available